ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
VistaGen Reports Positive New Data from AV-101, Probenecid Study americanpharmaceuticalreview
September 07, 2020VistaGen Therapeutics announced positive new data from the Company's second preclinical study of its oral investigational drug, AV-101, in combination with probenecid. Probenecid has extensive data supporting its safe oral delivery and ability to ...
Pharma Sources Insight January 2025
